Vanguard Group Inc Royalty Pharma PLC Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Vanguard Group Inc holds 10,936,538 shares of RPRX stock, worth $428 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,936,538
Previous 36,377,678 69.94%
Holding current value
$428 Million
Previous $1.31 Billion 70.56%
% of portfolio
0.01%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$34.9 - $37.91 $888 Million - $964 Million
-25,441,140 Reduced 69.94%
10,936,538 $386 Million
Q2 2025

Aug 11, 2025
SELL
$30.85 - $36.14 $9.25 Million - $10.8 Million
-299,770 Reduced 0.82%
36,377,678 $1.31 Billion
Q1 2025

May 09, 2025
SELL
$25.75 - $33.86 $17.4 Million - $22.9 Million
-676,561 Reduced 1.81%
36,677,448 $1.14 Billion
Q4 2024

Feb 11, 2025
SELL
$24.28 - $28.39 $5.61 Million - $6.56 Million
-231,114 Reduced 0.61%
37,354,009 $953 Million
Q3 2024

Nov 13, 2024
SELL
$25.63 - $29.27 $11.2 Million - $12.8 Million
-437,258 Reduced 1.15%
37,585,123 $1.06 Billion
Q2 2024

Aug 13, 2024
BUY
$26.26 - $29.9 $8.47 Million - $9.65 Million
322,699 Added 0.86%
38,022,381 $1 Billion
Q1 2024

May 10, 2024
SELL
$27.46 - $31.33 $8.18 Million - $9.33 Million
-297,840 Reduced 0.78%
37,699,682 $1.14 Billion
Q4 2023

Feb 14, 2024
SELL
$26.21 - $29.22 $37.7 Million - $42.1 Million
-1,439,832 Reduced 3.65%
37,997,522 $1.07 Billion
Q3 2023

Nov 14, 2023
BUY
$26.26 - $31.38 $15.5 Million - $18.5 Million
589,558 Added 1.52%
39,437,354 $1.07 Billion
Q2 2023

Aug 14, 2023
BUY
$29.6 - $36.56 $27.2 Million - $33.6 Million
917,777 Added 2.42%
38,847,796 $1.19 Billion
Q1 2023

May 15, 2023
BUY
$32.77 - $39.4 $75.4 Million - $90.7 Million
2,302,228 Added 6.46%
37,930,019 $1.37 Billion
Q4 2022

Feb 10, 2023
BUY
$39.17 - $44.04 $26.5 Million - $29.8 Million
675,981 Added 1.93%
35,627,791 $1.41 Billion
Q3 2022

Nov 14, 2022
BUY
$39.88 - $44.65 $83.7 Million - $93.7 Million
2,098,034 Added 6.39%
34,951,810 $1.4 Billion
Q2 2022

Aug 12, 2022
BUY
$37.53 - $44.22 $37.3 Million - $43.9 Million
993,155 Added 3.12%
32,853,776 $1.38 Billion
Q1 2022

May 13, 2022
BUY
$37.46 - $42.44 $83.3 Million - $94.4 Million
2,224,056 Added 7.5%
31,860,621 $1.24 Billion
Q4 2021

Feb 14, 2022
SELL
$35.17 - $42.48 $13.8 Million - $16.6 Million
-391,497 Reduced 1.3%
29,636,565 $1.18 Billion
Q3 2021

Nov 12, 2021
BUY
$36.14 - $42.24 $205 Million - $240 Million
5,685,862 Added 23.36%
30,028,062 $1.09 Billion
Q2 2021

Aug 13, 2021
BUY
$39.85 - $46.63 $970 Million - $1.14 Billion
24,342,200 New
24,342,200 $998 Million

Others Institutions Holding RPRX

# of Institutions
536
Shares Held
304M
Call Options Held
1.34M
Put Options Held
252K
View Full List

About Royalty Pharma plc

RPRX Quotes by TradingView
  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $17.1B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email